Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Cardiotoxicity 5Neoplasms 3Breast Neoplasms 3Heart Failure 2Dyslipidemias 2Cardiovascular Diseases 2Ventricular Dysfunction, Left 1Thoracic Neoplasms 1Smoking 1Pulmonary Disease, Chronic Obstructive 1Overweight 1Obesity 1Noncommunicable Diseases 1Metabolic Syndrome 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypokinesia 1Hypertension 1Hyperglycemia 1Diabetes Mellitus 1Coronary Disease 1Cerebrovascular Disorders 1Central Nervous System Neoplasms 1Cardiomyopathies 1Atrial Fibrillation 1Asthma 1Alcohol Drinking 1

Interventions

Echocardiography 3Electrocardiography 2Blood Specimen Collection 2ziprasidone 1Zolpidem 1Watchful Waiting 1Warfarin 1Vecuronium Bromide 1Vascular Stiffness 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Surveys and Questionnaires 1Standard of Care 1Spironolactone 1Specimen Handling 1Sevelamer 1Rocuronium 1Pulse Wave Analysis 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Lenalidomide 1Labetalol 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Heart Failure × Electrocardiography × Clear all
NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

NCT05939089 2023-07-11

CASPER

Istanbul University

Completed
54 enrolled

Heart Failure, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡